BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 38578016)

  • 1. Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms.
    Agarwal K; Luk JW; Stangl BL; Schwandt ML; Momenan R; Goldman D; Diazgranados N; Kareken DA; Leggio L; Ramchandani VA; Joseph PV
    J Addict Med; 2024 May; ():. PubMed ID: 38776446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
    Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
    Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Well-being in patients with olfactory dysfunction.
    Mai Y; Menzel S; Cuevas M; Haehner A; Hummel T
    Physiol Behav; 2022 Oct; 254():113899. PubMed ID: 35809697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the prognostic significance of qualitative olfactory dysfunction.
    Reden J; Maroldt H; Fritz A; Zahnert T; Hummel T
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):139-44. PubMed ID: 17006637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of odor hedonic perception: the Sniffin' sticks parosmia test (SSParoT).
    Liu DT; Welge-Lüssen A; Besser G; Mueller CA; Renner B
    Sci Rep; 2020 Oct; 10(1):18019. PubMed ID: 33093474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parosmia and Phantosmia: Managing Quality Disorders.
    Altundag A
    Curr Otorhinolaryngol Rep; 2023; 11(1):19-26. PubMed ID: 36721659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination.
    Hernandez AK; Landis BN; Altundag A; Fjaeldstad AW; Gane S; Holbrook EH; Huart C; Konstantinidis I; Lechner M; Macchi A; Portillo Mazal P; Miwa T; Philpott CM; Pinto JM; Poletti SC; Vodicka J; Welge-Luessen A; Whitcroft KL; Hummel T
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(6):312-320. PubMed ID: 37062268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction.
    Hoffman HJ; Rawal S; Li CM; Duffy VB
    Rev Endocr Metab Disord; 2016 Jun; 17(2):221-40. PubMed ID: 27287364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
    Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
    Laryngoscope; 2024 Apr; ():. PubMed ID: 38578016
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.